Pharmacology and Therapeutics

Top Research Topics at Pharmacology & Therapeutics?

The journal mainly tackles studies in Pharmacology, Internal medicine, Biochemistry, Endocrinology and Immunology. The study on Pharmacology presented in Pharmacology & Therapeutics intersects with the topics under Receptor. The journal focuses on Receptor but the discussions also offer insight into other areas such as Signal transduction and Neuroscience.

The Internal medicine works featured in the journal incorporate elements from Oncology and Cardiology. It focuses on Biochemistry as well as the interrelated topic of Cell biology. The research on Immunology featured in it combines topics in other fields like Cancer research and Disease.

Cancer research and Cancer cell are closely related fields of research discussed in the journal. The research on Disease discussed in Pharmacology & Therapeutics draws on the closely related field of Bioinformatics.

• Pharmacology (20.48%)
• Internal medicine (18.30%)
• Biochemistry (16.49%)

What are the most cited papers published in the journal?

• The biochemistry and medical significance of the flavonoids. (1963 citations)
• Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation (1938 citations)
• Mechanisms involved in the side effects of glucocorticoids (1349 citations)

Research areas of the most cited articles at Pharmacology & Therapeutics:

The journal publications mainly tackle studies in Biochemistry, Pharmacology, Internal medicine, Receptor and Endocrinology. The studies on Internal medicine discussed at the journal articles can also contribute to research in the domains of Bioinformatics and Cardiology. The journal articles hold forums on Receptor that merge themes from other disciplines such as Signal transduction, Neuroscience and Immunology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Enzyme

The previous edition focused in particular on these issues:

Pharmacology & Therapeutics mostly deals with topics like Cancer research, Cancer, Immune system, Neuroscience and Bioinformatics. While the primary focus in the journal is Cancer research, it also dissects topics surrounding Antigen and Antibody as a whole. Research in Immune system discussed is concerned with the study of Immunology as a whole.

The work on Neuroscience tackled in the journal brings together disciplines like Receptor, Neuroinflammation and Programmed cell death. Topics in Receptor were tackled in line with various other fields like Signal transduction, Cell biology, Pharmacology and Drug discovery. The studies on Bioinformatics discussed can also contribute to research in the domains of Disease and Drug.

The most cited articles from the last journal are:

• Carcinogenesis: Failure of resolution of inflammation? (23 citations)
• G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects. (16 citations)
• NRF2 in human neoplasm: Cancer biology and potential therapeutic target. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Pharmacology & Therapeutics (based on the number of publications) are:

• Gary M. Williams (11 papers) absent at the last edition,
• John Whysner (10 papers) absent at the last edition,
• Devanand Sarkar (8 papers) absent at the last edition,
• Paul B. Fisher (8 papers) absent at the last edition,
• Derek J. Hausenloy (7 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacology & Therapeutics (based on the number of publications) are:

• National Institutes of Health (125 papers) published 8 papers at the last edition, 2 more than at the previous edition,
• French Institute of Health and Medical Research (58 papers) absent at the last edition,
• Harvard University (53 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• University of Melbourne (50 papers) published 1 paper at the last edition, 1 less than at the previous edition,
• King's College London (34 papers) published 2 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.54% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 8.26% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.68% of all publications and 72.02% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Preparing for a Career in Pharmacological Research

If you're interested in contributing to the studies and discoveries made in Pharmacology & Therapeutics, it's important to understand the journey ahead and what prerequisites or qualifications are needed. Typically, the roadmap to a career in pharmacological research starts with an undergraduate degree in subjects like Biochemistry, Pharmacology or related life science disciplines. This is usually followed by a Master's degree and eventually, a Ph.D. in a specialized topic. However, the academic requirements can slightly differ based on the specific field of research and the country where you plan to work. For instance, those wishing to embark on pharmacological research careers in North Carolina will have to adhere to certain licensure requirements. Detailed information about these requirements are outlined by the [North Carolina nursing license requirements board of nursing requirements](https://research.com/careers/north-carolina-nursing-license-requirements). In addition to educational qualifications, certain skills and attributes are also crucial. These include a profound understanding of clinical medicine, familiarity with laboratory procedures, strong analytical skills, and the patience to conduct repetitive tasks. Furthermore, the ability to work collaboratively in a team is essential given the interdisciplinary nature of pharmacological research, which often requires collaborations with experts from other fields like Oncology, Cardiology, and Bioinformatics.